Kotak Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
NAV: ₹16.53-0.88%
08 Jul 2026
Loading…
| Asset | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Equity | 98.87% | 99.02% | 99.35% | 98.73% | 98.25% | 96.25% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 1.13% | 0.98% | 0.65% | 1.27% | 1.75% | 3.75% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 4,05,000 | 72.87 | 13.01% | -1.03%↓ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 1,61,000 | 34.9 | 6.23% | -0.40%↓ |
| Divis Laboratories Ltd. | Healthcare | 50,000 | 33.34 | 5.95% | 0.05%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 3,15,000 | 30.4 | 5.43% | -0.88%↓ |
| Cipla Ltd. | Healthcare | 2,00,000 | 28.02 | 5.00% | 0.78%↑ |
| Acutaas Chemicals Ltd. | Healthcare | 88,000 | 27.57 | 4.92% | 0.32%↑ |
| Fortis Healthcare Ltd. | Healthcare | 2,60,000 | 24.14 | 4.31% | -0.53%↓ |
| Park Medi World Ltd. | Healthcare | 8,15,000 | 23.52 | 4.20% | 0.41%↑ |
| Mankind Pharma Ltd. | Healthcare | 75,000 | 17.82 | 3.18% | 0.46%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 2,30,000 | 17.45 | 3.12% | -0.44%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 20,000 | 16.35 | 2.92% | -0.16%↓ |
| Sai Life Sciences Ltd. | Healthcare | 1,40,000 | 16.24 | 2.90% | -0.12%↓ |
| Lupin Ltd. | Healthcare | 65,000 | 14.74 | 2.63% | -0.39%↓ |
| Anthem Biosciences Ltd. | Healthcare | 1,80,000 | 13.68 | 2.44% | -0.01%↓ |
| Jubilant Pharmova Ltd. | Healthcare | 1,35,000 | 13.43 | 2.40% | -0.12%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 89,890 | 12.82 | 2.29% | -0.35%↓ |
| Marksans Pharma Ltd. | Healthcare | 5,00,000 | 12.31 | 2.20% | 0.34%↑ |
| Ajanta Pharma Ltd. | Healthcare | 42,000 | 12.3 | 2.20% | -0.19%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 50,000 | 11.37 | 2.03% | -0.40%↓ |
| Gland Pharma Ltd. | Healthcare | 50,000 | 11.25 | 2.01% | 0.25%↑ |
| Sector | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Healthcare | 98.65% | 98.79% | 99.13% | 98.48% | 97.96% | 96.25% |
| Services | 0.22% | 0.23% | 0.22% | 0.25% | 0.29% | - |
27.0 / 100
Weighted average Value score is 27.0. This indicates that portfolio is relatively reasonably valued using composite of value measures.
80.8 / 100
Weighted average Price Momentum score is 80.8. This indicates that portfolio has high momentum using composite of momentum measures.
86.9 / 100
Weighted average Quality score is 86.9. This indicates that portfolio has high quality using composite of quality measures.
76.8 / 100
Weighted average QVM score is 76.8. This indicates that portfolio has high QVM score and hence could be considered for investment.